Cost-effectiveness analysis of Shexiang Baoxin Pill (MUSKARDIA) as the add-on treatment to standard therapy for stable coronary artery disease in China

• Jie Pan,

  Roles Data curation, Formal analysis, Methodology, Writing – original draft, Writing – review & editing

  Affiliation School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China

  ⨯
• Ping-da Ping,

  Roles Data curation, Formal analysis, Validation

  Affiliation School of Management, Beijing University of Chinese Medicine, Beijing, China

  ⨯
• Wei Wang,

  Roles Data curation, Formal analysis, Validation

  Affiliation School of Management, Beijing University of Chinese Medicine, Beijing, China

  ⨯
• Jia-meng Zhou,

  Roles Data curation, Formal analysis, Validation

  Affiliation School of Management, Beijing University of Chinese Medicine, Beijing, China

  ⨯
• Wen-tao Zhu

  Roles Conceptualization, Methodology, Project administration, Supervision, Validation, Writing – review & editing

  * E-mail: zhuwt@bucm.edu.cn

  Affiliation School of Management, Beijing University of Chinese Medicine, Beijing, China

  https://orcid.org/0000-0002-1123-2777

  ⨯